Taina Härkönen

4.7k total citations · 2 hit papers
80 papers, 3.0k citations indexed

About

Taina Härkönen is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Taina Härkönen has authored 80 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Genetics, 41 papers in Endocrinology, Diabetes and Metabolism and 40 papers in Surgery. Recurrent topics in Taina Härkönen's work include Diabetes and associated disorders (67 papers), Pancreatic function and diabetes (40 papers) and Diabetes Management and Research (35 papers). Taina Härkönen is often cited by papers focused on Diabetes and associated disorders (67 papers), Pancreatic function and diabetes (40 papers) and Diabetes Management and Research (35 papers). Taina Härkönen collaborates with scholars based in Finland, Estonia and United States. Taina Härkönen's co-authors include Mikael Knip, Jorma Ilonen, Samppa Ryhänen, Heli Siljander, Tommi Vatanen, Ramnik J. Xavier, Outi Vaarala, Hera Vlamakis, Anu‐Maaria Hämäläinen and Curtis Huttenhower and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Taina Härkönen

79 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability

2016 714 citations Tommi Vatanen, Heli Siljander et al. profile →
Fecal Microbiota Composition Differs Between Children With β-Cell Autoimmunity and Those Without

2012 436 citations Kristiina Luopajärvi, Mikael Knip et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taina Härkönen Finland	26	1.4k	1.2k	873	836	512	80	3.0k
Heli Siljander Finland	23	1.2k 0.9×	1.3k 1.1×	844 1.0×	821 1.0×	497 1.0×	48	3.1k
Tuula Simell Finland	29	3.4k 2.5×	1.4k 1.2×	2.5k 2.8×	2.3k 2.8×	502 1.0×	54	5.3k
Laura Stronati Italy	34	582 0.4×	1.4k 1.2×	175 0.2×	562 0.7×	229 0.4×	87	3.3k
Tatiana Takiishi Belgium	13	417 0.3×	688 0.6×	322 0.4×	324 0.4×	255 0.5×	18	2.6k
Stacy Weitsman United States	32	387 0.3×	937 0.8×	319 0.4×	338 0.4×	842 1.6×	70	4.0k
Suzanne Devkota United States	22	555 0.4×	2.3k 1.9×	171 0.2×	442 0.5×	479 0.9×	46	3.5k
Diana Ir United States	29	360 0.3×	1.4k 1.2×	195 0.2×	355 0.4×	335 0.7×	54	2.6k
Rodrigo Quera Chile	22	1.0k 0.8×	2.3k 1.9×	123 0.1×	887 1.1×	536 1.0×	147	4.6k
Valentina Petito Italy	29	677 0.5×	2.3k 1.9×	145 0.2×	518 0.6×	587 1.1×	85	4.2k
Kendle M. Maslowski Switzerland	16	517 0.4×	3.1k 2.6×	224 0.3×	509 0.6×	712 1.4×	25	4.7k

Countries citing papers authored by Taina Härkönen

Since Specialization

Citations

This map shows the geographic impact of Taina Härkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taina Härkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taina Härkönen more than expected).

Fields of papers citing papers by Taina Härkönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taina Härkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taina Härkönen. The network helps show where Taina Härkönen may publish in the future.

Co-authorship network of co-authors of Taina Härkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Taina Härkönen. A scholar is included among the top collaborators of Taina Härkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taina Härkönen. Taina Härkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hyöty, Heikki, Jutta E. Laiho, Gail M. Comer, et al.. (2024). Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia. 67(5). 811–821. 11 indexed citations

Koskenniemi, Jaakko J., Paula Vähäsalo, Taina Härkönen, et al.. (2023). Extremely Early Appearance of Islet Autoantibodies in Genetically Susceptible Children. Pediatric Diabetes. 2023. 1–19.

Knip, Mikael, Anna But, Taina Härkönen, et al.. (2023). SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study. The Lancet Diabetes & Endocrinology. 11(4). 251–260. 29 indexed citations

Kettunen, Jarno L. T., Taina Härkönen, Om Prakash Dwivedi, et al.. (2022). Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register. Diabetologia. 66(3). 438–449. 15 indexed citations

Laajala, Essi, Taina Härkönen, Sini Junttila, et al.. (2022). Early DNA methylation changes in children developing beta cell autoimmunity at a young age. Diabetologia. 65(5). 844–860. 12 indexed citations

Hakola, Leena, Iris Erlund, David Cuthbertson, et al.. (2021). Serum fatty acids and risk of developing islet autoimmunity: A nested case–control study within the TRIGR birth cohort. Pediatric Diabetes. 22(4). 577–585. 11 indexed citations

Härkönen, Taina, Jorma Ilonen, Jorma Toppari, et al.. (2021). Autoantibodies to N-terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 107(3). e935–e946. 6 indexed citations

Härkönen, Taina, Paula Vähäsalo, Johanna Lempainen, et al.. (2021). Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes. Pediatric Diabetes. 23(2). 219–227. 6 indexed citations

Kiviniemi, Minna, Antti‐Pekka Laine, Johanna Lempainen, et al.. (2020). HLA‐DR‐DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity. Pediatric Diabetes. 21(7). 1218–1226. 18 indexed citations

10.

Parkkola, Anna, et al.. (2020). Family history of type 2 diabetes and characteristics of children with newly diagnosed type 1 diabetes. Diabetologia. 64(3). 581–590. 15 indexed citations

11.

Yeo, Lorraine, Irma Pujol‐Autonell, Ricardo Baptista, et al.. (2019). Circulating β cell-specific CD8+ T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes. Clinical & Experimental Immunology. 199(3). 263–277. 26 indexed citations

12.

Salo, Harri M., Jani Koponen, Hannu Kiviranta, et al.. (2019). No evidence of the role of early chemical exposure in the development of β-cell autoimmunity. Tampere University Institutional Repository (Tampere University). 2 indexed citations

13.

Härkönen, Taina, et al.. (2019). Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis. Diabetologia. 62(11). 2025–2039. 35 indexed citations

14.

Zhao, Guoyan, Tommi Vatanen, Lindsay Droit, et al.. (2017). Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proceedings of the National Academy of Sciences. 114(30). E6166–E6175. 212 indexed citations

15.

Parkkola, Anna, Antti‐Pekka Laine, Markku Karhunen, et al.. (2017). HLA and non-HLA genes and familial predisposition to autoimmune diseases in families with a child affected by type 1 diabetes. PLoS ONE. 12(11). e0188402–e0188402. 15 indexed citations

16.

Knip, Mikael, Kristiina Luopajärvi, & Taina Härkönen. (2017). Early life origin of type 1 diabetes. Seminars in Immunopathology. 39(6). 653–667. 23 indexed citations

17.

Galli, Emilia, Taina Härkönen, Mart Ustav, et al.. (2016). Increased circulating concentrations of mesencephalic astrocyte-derived neurotrophic factor in children with type 1 diabetes. Scientific Reports. 6(1). 29058–29058. 54 indexed citations

18.

Ronkainen, Matti S, Taina Härkönen, Jaakko Perheentupa, & Mikael Knip. (2005). Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes. European Journal of Endocrinology. 153(6). 901–906. 6 indexed citations

19.

Härkönen, Taina, et al.. (2003). Coxsackievirus immunization delays onset of diabetes in non‐obese diabetic mice. Journal of Medical Virology. 69(4). 510–520. 18 indexed citations

20.

Tikkanen, Matti J., et al.. (1991). Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot‐medroxyprogesterone acetate. Acta Obstetricia Et Gynecologica Scandinavica. 70(4-5). 349–354. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact